BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1564937)

  • 1. Is the primary event in radiation-induced chronic myelogenous leukemia the induction of the t(9;22) translocation?
    Holmberg M
    Leuk Res; 1992; 16(4):333-6. PubMed ID: 1564937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 9;22 translocation and bcr rearrangements in chronic myelocytic leukemia patients among atomic bomb survivors.
    Tanaka K; Takechi M; Hong J; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Dohy H; Kyo T
    J Radiat Res; 1989 Dec; 30(4):352-8. PubMed ID: 2614751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the low-LET dose-response of BCR-ABL formation: predicting stem cell numbers from A-bomb data.
    Radivoyevitch T; Hoel DG
    Math Biosci; 1999; 162(1-2):85-101. PubMed ID: 10616282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis X.
    Chap L; Nimer SD
    Leuk Lymphoma; 1994 Jan; 12(3-4):315-6. PubMed ID: 8167563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologically based risk estimation for radiation-induced CML. Inferences from BCR and ABL geometric distributions.
    Radivoyevitch T; Kozubek S; Sachs RK
    Radiat Environ Biophys; 2001 Mar; 40(1):1-9. PubMed ID: 11357705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiation-related CML].
    Kamada N
    Nihon Rinsho; 2001 Dec; 59(12):2329-35. PubMed ID: 11766334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene rearrangement and radiation carcinogenesis].
    Akiyama M
    Rinsho Ketsueki; 1994 May; 35(5):454-60. PubMed ID: 8028192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.
    Al-Achkar W; Wafa A; Nweder MS
    J Exp Clin Cancer Res; 2007 Sep; 26(3):411-5. PubMed ID: 17987804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
    Xue YQ
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic myeloid leukemia with variation of translocation at (Ph) [ins (22;9) (q11;q21q34)]: a case report.
    Wang Z; Zen W; Meng F; Xin X; Luo L; Sun H; Zhou J; Huang L
    Int J Clin Exp Pathol; 2015; 8(10):13707-10. PubMed ID: 26722598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel complex t(V;9;22) rearrangements in three cases with chronic myeloid leukemia and a rare translocation in a case with classical Philadelphia chromosome.
    Mkrtchyan H; Ghazaryan S; Avetisyan G; Hovhannisyan A; Muradyan L; Daghbashyan S; Karst C; Gross M; Hinreiner S; Aroutiounian R; Liehr T
    Oncol Rep; 2008 Jul; 20(1):99-104. PubMed ID: 18575724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A complex three-way translocation with deletion of the TP53 gene in a blast crisis chronic myeloid leukemia patient.
    Kokate P; Dalvi R; Mandava S
    J Cancer Res Ther; 2015; 11(4):1037. PubMed ID: 26881646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first BCR gene intron contains breakpoints in Philadelphia chromosome positive leukemia.
    Heisterkamp N; Knoppel E; Groffen J
    Nucleic Acids Res; 1988 Nov; 16(21):10069-81. PubMed ID: 3194194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
    Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
    Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex karyotype with a masked Philadelphia translocation and variant BCR-ABL fusion in CML.
    Bakshi SR; Patel BP; Brahmbhatt MM; Trivedi PJ; Gajjar SB; Iyer RR; Parikh EH; Shukla SN; Shah PM
    Cancer Genet Cytogenet; 2009 Mar; 189(2):142-3. PubMed ID: 19215799
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation.
    Mancini M; Nanni M; Cedrone M; De Cuia MR; Rondinelli MB; Malagnino F; Alimena G
    Haematologica; 1994; 79(6):536-9. PubMed ID: 7896212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible evidence for acquired genetic activity at both chromosomal breakpoints of the Philadelphia translocation in chronic myeloid leukemia.
    Yamada T; Secker-Walker LM
    Leukemia; 1990 May; 4(5):341-4. PubMed ID: 2388479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in laboratory medicine in chronic myeloid leukemia].
    Miura A
    Rinsho Byori; 1998 Dec; 46(12):1226-31. PubMed ID: 9916508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of BCR/ABL Fusion Gene by Hematological and Cytogenetical Analysis in Chronic Myeloid Leukemia Patients in Quetta, Pakistan.
    Tahira B; Asif M; Khan S; Hussain A; Shahwani MN; Malik A; Inayatullah S; Iqbal Z; Rasool M
    Asian Pac J Cancer Prev; 2015; 16(9):3793-7. PubMed ID: 25987039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.